Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/23159
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 17109/19415 (88%)
造访人次 : 2690348      在线人数 : 585
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    標題: A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA
    作者: Meng-ChiYen
    Chi-Chen Lin
    Yi-Ling Chen
    Shih-Shien Huang
    Chih-Peng Chang
    Huan-Yao Lei
    Ming-Derg Lai
    貢獻者: 老人服務事業管理系
    日期: 2009-01
    上傳時間: 2010-10-28 16:05:39 (UTC+8)
    摘要: Purpose: Indoleamine 2,3-dioxygenase (IDO), an enzyme that degrades tryptophan, is a negative immune regulatorym olecule of dendritic cells. IDO-expressing dendritic cells suppress Tcell responses and maybe immunosuppressive in vivo.We hypothesized that silencing the IDO expression in skin dendritic cells in vivo could elicit antitumor activityi n tumor-draining lymph nodes.
    Experimental Design: The efficiencyo f IDO-specific small interfering RNA (siRNA) was evaluated in vitro and in vivo. The therapeutic effect was evaluated in MBT-2 murine bladder tumor model and CT-26 colon tumor models.
    Results: IDO expression was down-regulated in CD11c-positive lymphocytes after IDO siRNA treatment. In vivo skin administration of IDO siRNA inhibited tumor growth and prolonged survival in both tumor models. The number of infiltrated Tcells and neutrophils increased at tumor sites, which are correlated with therapeutic efficacy.TheTcells may be mainly responsible for the immunologic rejection because the effect was abolished byd epletion of CD8-positiveT cells.
    Adoptive transfer of CD11c-positive dendritic cells from vaccinated mice delayed tumor progression. The cancer therapeutic effect was reproduciblyobservedwith another IDO siRNA targeting at different site, suggesting the effect was not due to off-target effect. In a neu-overexpressing MBT-2 tumor model, IDO siRNA enhanced the therapeutic efficacyo f Her2/Neu DNA vaccine. Down-regulation of IDO2, an IDO homologue, with siRNA also generated antitumor immunity
    in vivo.
    Conclusions: Antitumor immunityca n be effectively elicited by physical deliveryof siRNAs targeting immunoregulatoryg enes in skin dendritic cells in vivo, as shown byI DO and IDO2 in this report.
    显示于类别:[老人服務事業管理系] 期刊論文


    档案 描述 大小格式浏览次数

    在CNU IR中所有的数据项都受到原著作权保护.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈